Orchid Pharma Limited · NSE:ORCHPHARMA

Orchid Pharma — Q1 FY24 Earnings Presentation

10 slides from Orchid Pharma's earnings presentation, Aug 14, 2023

  1. Slide 1: Investors Presentation Q1 FY24 – Exchange Filing Cover Letter

    August 14, 2023 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Subject: Investors Presentation Q1 FY24 – Orchid Pharma Limited (“th

  2. Slide 2: Q1-FY24 Results

    Q1-FY24 Results © Copyright OrchidPharma Ltd. All Rights Reserved 1

  3. Slide 3: Safe Harbor

    SAFE HARBOR FY2023 This presentation and the accompanying slides (the “Presentation”), which have been prepared by Orchid Pharma Ltd (the “Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secu

  4. Slide 4: Total Income

    FY2023 TOTAL INCOME 800 700 685 600 566 500 400 300 200 185 134 100 0 FY22 FY23 Q1-FY23 Q1-FY24 © Copyright OrchidPharma Ltd. All Rights Reserved 3

  5. Slide 5: EBITDA

    FY2023 EBITDA 120 16% 15% 103 14% 100 13% 12% 12% 80 11% 10% 66 60 8% 6% 40 24 4% 20 15 2% 0 0% FY22 FY23 Q1-FY23 Q1-FY24 EBITDA %age Income © Copyright OrchidPharma Ltd. All Rights Reserved 4

  6. Slide 6: PAT

    FY2023 PAT 20 16 8% 11 6% 6% 10 4% 0 FY22 2% FY23 Q1-FY23 Q1-FY24 2% -10 0% -14 -20 -2% -4% -30 -6% -40 -8% -50 -9% -10% -53 -11% -60 -12% PAT %age Income © Copyright OrchidPharma Ltd. All Rights Reserved 5

  7. Slide 7: Expense Breakup

    FY2023 EXPENSE BREAKUP 140 40% 132 125 36% 120 35% 33% 30% 100 29% 26% 25% 80 65 20% 60 60 15% 40 34 32 10% 20 15 16 5% 0 0% FY22 FY23 Q1-FY23 Q1-FY24 Employee Expense Other Expenses %age Income © Copyright OrchidPharma Ltd. All Rights Reserved 6

  8. Slide 8: Leverage

    FY2023 LEVERAGE 40% 38% 36% 35% 30% 25% 24% 21% 21% 20% 18% 15% 12% 10% 8% 5% 0% FY22 FY23 Q1-FY23 Q1-FY24 %increase in total Income %increase/dec in expenses © Copyright OrchidPharma Ltd. All Rights Reserved 7

  9. Slide 9: Summary Results

    FY2023 SUMMARY RESULTS Rs. In Cr. Particulars Year 2022-23 Year 2021-22 Q1-FY23 Q1-FY24 Net Sales/Income from Operations 666 557 131 183 Other Income 19 9 3 2 Total Income 685 566 134 185 Raw Material Cost 385 314 69 112 Employee benefit expenses 65 60 15 16 Finance Costs 32 32 8 6 Depreciation & am

  10. Slide 10: Thank You!

    Thank You! © Copyright OrchidPharma Ltd. All Rights Reserved 9

Orchid Pharma — Q1 FY24 Earnings Presentation on 6ix